NATALEE REIF: Open Payments
NPI 1548928641 · MONTGOMERY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 34 payments from 10 companies in 2025. Trend: 2023 $217 · 2024 $694 · 2025 $784
Food & beverage: $776Education: $8
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $257 |
| Amgen Inc. | 4 | $156 |
| Novartis Pharmaceuticals Corporation | 5 | $82 |
| PFIZER INC. | 5 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| Kestra Medical Technology Services, Inc. | 2 | $45 |
| Merck Sharp & Dohme LLC | 3 | $43 |
| Edwards Lifesciences Corporation | 1 | $41 |
| Daiichi Sankyo Inc. | 1 | $20 |
| BridgeBio Pharma, Inc. | 1 | $17 |
Products named: Kerendia, REPATHA, LEQVIO, VYNDAQEL, JARDIANCE, Assure WCD, VERQUVO, SAPIEN 3 Ultra RESILIA.
Industry payments across OH — which companies pay providers there.
